DAIICHI SANKYO CO., LTD.

(4568)
  Rapport
Temps Différé Japan Exchange  -  26/05 08:00:00
3462.00 JPY   -0.37%
25/05Le Nikkei 225 recule de 0,3 % en raison du renforcement du yen
MT
19/05Jacobs remporte un contrat pour soutenir le nettoyage de la centrale nucléaire japonaise de Fukushima
MT
05/05AstraZeneca, Daiichi Sankyo déclarent que la FDA américaine autorise Enhertu pour le traitement du cancer du sein ; Ultomiris d'AstraZeneca répond au critère principal d'évaluation
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur DAIICHI SANKYO CO., LTD.
25/05Nikkei 225 Slips 0.3% on Stronger Yen
25/05Japanese shares end lower on Wall Street weakness
25/05Japanese shares inch lower on Wall Street weakness
19/05Jacobs Wins Deal to Support Clean-Up of Japan's Fukushima Nuclear Plant
17/05LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recen..
05/05AstraZeneca, Daiichi Sankyo Say US FDA Clears Enhertu to Treat Breast Cancer; AstraZene..
05/05Enhertu approved in the US for patients with HER2-positive metastatic breast cancer tr..
05/05AstraZeneca, Daiichi's Breast Cancer Treatment Wins US Approval
05/05AstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer Treatment
28/04ENHERTU (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in t..
28/04AstraZeneca - Based on DESTINY-Breast04 results where AstraZeneca and Daiichi Sankyo's ..
28/04Daiichi Sankyo's FY22 Attributable Profit Falls 12% on Higher Expenses
27/04SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Wednesday
27/04AstraZeneca, Daiichi Sankyo Get FDA Breakthrough Therapy Designation for Breast Cancer ..
27/04Enhertu granted BTD for HER2-low breast cancer
27/04MÄRKTE ASIEN/Tokio und Seoul schwach - Erholungsrally in Schanghai
27/04TRANSCRIPT : Daiichi Sankyo Company, Limited, Q4 2022 Earnings Call, Apr 27, 2022
27/04AstraZeneca's Enhertu Gets US FDA's Breakthrough Therapy Designation In Breast Cancer T..
27/04AstraZeneca's Enhertu Drug Granted Breakthrough Therapy Designation in US
27/04DAIICHI SANKYO : Consolidated Financial Results for Year Ended March 31, 2022
27/04DAIICHI SANKYO : Reference Data
27/04DAIICHI SANKYO : FY2021 Financial Results Presentation
27/04ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Low Me..
26/04ViGeneron GmbH Announces Follow-On Collaboration with Daiichi Sankyo to Develop A Novel..
25/04Seagen Q1 Results May Bring Improved 2022 Guidance, Oppenheimer Says
19/04Enhertu granted Priority Review in the US for patients with previously treated HER2-mut..
19/04AstraZeneca, Daiichi Sankyo Say FDA Grants Priority Review to Supplemental Biologics Li..
19/04ASTRAZENECA/DAIICHI SANKYO : FDA prüft Enhertu vorrangig
19/04ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 ..
19/04AstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority Review
14/04Daiichi Sankyo - Our Response to the Situation in Ukraine
11/04Japan cancels a third of contracted Astrazeneca vaccine purchase
08/04Daiichi Sankyo Provides Update on Patent Dispute With Seagen
07/04Nikkei 225 Slides 1.97%, Extends Losses on Federal Reserve Outlook; IMF Cuts Japan GDP ..
31/03YaoPharma Co., Ltd. entered into an equity transfer agreement to acquire Daiichi Sankyo..
30/03AstraZeneca aims to transform the oncology treatment landscape with diverse early pipel..
25/03Nikkei 225 Up 0.1% On Lack of Cues, Dividend Buys
25/03Japanese shares slip after eight days of gains
23/03Nikkei 225 Up 3% on Wall Street Cues, Softer Yen
22/03Japan turns down the heat and dims the lights to avoid power cut after quake
17/03Mindestens vier Tote und viele Verletzte bei Erdbeben in Fukushima
17/03Tote und viele Verletzte bei Erdbeben in Fukushima
17/03Quake hits Japan off Fukushima coast, leaving two dead and reviving painful memories
17/03Quake hits Japan off Fukushima coast, leaving two dead and reviving painful memories
16/03Zwei Tote bei Erdbeben in Fukushima - Tsunami-Warnung aufgehoben
16/03Neues starkes Erdbeben in Fukushima weckt böse Erinnerungen
16/03Tsunami-Warnungen nach Beben in Japan aufgehoben
16/03Starkes Erdbeben erschüttert Fukushima - Tsunami-Warnung
16/03Japanese shares track Wall Street higher as oil prices drop
11/03Daiichi Sankyo commits USD $1 million in support of humanitarian efforts related to the..
11/03ELF JAHRE NACH TSUNAMI UND FUKUSHIMA : Die Erinnerung verblasst
04/03Japan's top court orders damages for Fukushima victims in landmark decision -NHK
03/03Notice of suspicious emails appearing to be from Daiichi Sankyo employees
24/02Nikkei ends at 15-month low after Russia attacks Ukraine
24/02Nikkei hits 1-month low on growing fears over invasion of Ukraine
22/02Cosette Pharmaceuticals Launches First Injectable Product - Prochlorperazine Edisylate ..
22/02Nikkei 225 Off 1.7% on Ukraine Outlook For Fourth-Straight Loss
22/02Enhertu significantly improved both progression-free and overall survival in DESTINY-Br..
22/02Astrazeneca und Daiichi erreichen mit Krebsmittel Studienziel
22/02AstraZeneca Reports Positive High-Level Results in Breast Cancer Treatment Enhertu Tria..
22/02El Nikkei cae un 1,7% por la intensificación de las tensiones geopolíticas -- Market Ta..
22/02Japan Index Sees Steady Losses; Daiichi Sankyo Shares Zoom 10%
22/02Japan's Nikkei ends lower for fourth day as Ukraine crisis worsens
22/02Nikkei tumbles over 2% as deepening Ukraine crisis weighs
21/02FTSE Flat, PMI Data Adds to Case for Another BoE Rate Increase
21/02AstraZeneca refuerza sus credenciales oncológicas con el éxito de un ensayo sobre el cá..
21/02AstraZeneca, Daiichi Sankyo Report Positive Trial Results for Enhertu Breast-Cancer Tre..
21/02AstraZeneca Reports 'Historic' Trial Results for Enhertu Cancer Treatment
21/02AstraZeneca boosts oncology credentials with breast cancer trial success
21/02AstraZeneca's Enhertu shows promise for broader breast cancer use
21/02AstraZeneca's Enhertu Improves Survival in Late-Stage Breast Cancer Study
21/02ENHERTU® Significantly Improved Both Progression-Free and Overall Survival in DESTINY-B..
07/02IAEA prüft Japans Pläne zur Verklappung von Fukushima-Kühlwasser
01/02Daiichi Sankyo's FY22 Nine-Month Profit Rises 24% on Higher Revenue
31/01EN DIRECTO DESDE LOS MERCADOS : Iberdrola, BBVA, Apple, BASF, Spotify, Vodafone, Citrix, R..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur DAIICHI SANKYO CO., LTD.